meta_pixel
Tapesearch Logo
Log in
CorbettReport.com - Feature Interviews

Interview 1590 - New World Next Week with James Evan Pilato

CorbettReport.com - Feature Interviews

The Corbett Report

Geopolitics, News, Nwo, Alternative, Media, History, Politics, Conspiracy, News & Politics

4.8653 Ratings

🗓️ 29 October 2020

⏱️ 24 minutes

🧾️ Download transcript

Summary

This week on the New World Next Week: the COVID-19 vaccine trials are not what you think they are; the IMF announces Bretton Woods 2.0; and Halloween creepiness abounds in the latest Hollywood/White House crossover.

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome back to New World next week. I'm James Corporate of Corporate Report.com.

0:13.6

And I'm James Evan Pallado for Mediumoniki.com. If you don't think central bank

0:17.0

digital currencies are coming, you're missing the big and important picture. And we've got that

0:22.5

big important picture. Plus, make America purge again. But first, how COVID-19 vaccine trials are

0:29.6

rigged. And we're going to see a lot of this. While vaccine makers insist any COVID-19 vaccine

0:35.0

reaching the market will have undergone rigorous testing. The way trial

0:39.0

protocols are designed suggest these vaccines will not have a significant impact on infection

0:44.7

rate, hospitalizations, or death. Shockingly, preventing infections with SARS-cove to the official

0:52.2

name of the killer disease, not a criterion for success in these

0:57.0

vaccine trials. James, this in some way reminds me of how so many courts have ruled, oh, the police don't actually have to protect you. And that solving SARS-CoV-2 is not a criteria for success in these vaccine trials. The only criterion for successful COVID-19

1:12.0

vaccine is a reduction of symptoms shared by both COVID-19 and, of course, the common cold.

1:19.6

In AstraZeneca's case, as we've reported, the interim analysis included 15 vaccine recipients.

1:24.8

The vaccine will be a success if 12 or fewer developed symptoms after

1:29.8

exposure to SARS-CoV-2 compared to 19 in the 25-person control group. At least two cases

1:36.5

of transverse myelitis, severe inflammation of the spinal cord, has been documented in

1:42.2

Astrozenicus trial, and the company, as we told you,

1:45.0

temporarily halted its trial in September 2020. I think just last week we told you about how

1:50.3

Johnson and Johnson also paused their trial due to an undisclosed, unexplained illness in one of

1:55.9

its participants. So if the vaccine can't reduce infection, can't reduce hospitalization, and can't reduce death,

2:04.1

then how's it going to end the pandemic?

2:06.2

And it means anybody who takes this will be doing so in vain.

2:09.7

And it seems like so many of these things are essentially, it's a religious kind of cult operation.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Corbett Report, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Corbett Report and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.